Bloodless vascular surgery: A useful contradiction

Introduction Bloodless vascular surgery represents a transformative paradigm in modern surgical practice, aiming to minimize or eliminate allogeneic blood transfusions while optimizing patient outcomes. Given the well-documented risks associated with transfusions such as infections, immune reactions, and increased morbidity/mortality, this comprehensive approach has gained significant traction, particularly in complex vascular procedures historically prone to substantial blood loss. This manuscript provides an in-depth review of the multifaceted strategies employed in bloodless vascular surgery, emphasizing their scientific rationale and clinical application. Discussion Key components of a successful bloodless program include meticulous preoperative patient optimization, focusing on anemia management through oral and intravenous iron supplementation, and the judicious use of erythropoietin-stimulating agents. Intraoperatively, the adoption of minimally invasive techniques such as endovascular, laparoscopic, and robotic-assisted approaches significantly reduces surgical trauma and blood loss. Furthermore, precise point-of-care testing - notably thromboelastography (TEG) and rapid hemoglobin/fibrinogen assessments - enable real-time, targeted management of coagulopathies, moving beyond empirical transfusion protocols. Strategies for optimizing tissue oxygenation, controlled hypotension, acute normovolemic hemodilution, and the use of modern cell salvage techniques further conserve patients' blood. Pharmacological interventions including antifibrinolytics like tranexamic acid, desmopressin, and vitamin K are critically reviewed for their role in enhancing hemostasis. Conclusions Implementing such a program demands a collaborative, multidisciplinary team comprising anesthesiologists, surgeons, nurses, alongside support from blood banks, hematology, and hospital administration. This underscores how efficient bloodless surgery is a unified institutional effort. The benefits extend beyond clinical safety to include reduced healthcare costs and improved patient satisfaction. As advancements continue in surgical techniques, hemostatic agents, and personalized blood management strategies, bloodless vascular surgery is poised to become the standard of care for vascular interventions, promising enhanced safety and superior outcomes for patients globally.